Uses and abuses of tumor markers in the diagnosis, monitoring, and treatment of primary and metastatic breast cancer
Learning Objectives After completing this course, the reader will be able to: Identify the
difference between prognostic and predictive factors. Describe the evaluation of tumor
markers, including their utility, magnitude, and reliability. Discuss issues surrounding tumor
markers currently in routine use in breast cancer, including estrogen receptor, Her-2/neu,
and Oncotype DX™. Access and take the CME test online and receive 1 AMA PRA category
1 credit at CME. TheOncologist. com
difference between prognostic and predictive factors. Describe the evaluation of tumor
markers, including their utility, magnitude, and reliability. Discuss issues surrounding tumor
markers currently in routine use in breast cancer, including estrogen receptor, Her-2/neu,
and Oncotype DX™. Access and take the CME test online and receive 1 AMA PRA category
1 credit at CME. TheOncologist. com
Learning Objectives
After completing this course, the reader will be able to:
- Identify the difference between prognostic and predictive factors.
- Describe the evaluation of tumor markers, including their utility, magnitude, and reliability.
- Discuss issues surrounding tumor markers currently in routine use in breast cancer, including estrogen receptor, Her-2/neu, and Oncotype DX™.
Access and take the CME test online and receive 1 AMA PRA category 1 credit at CME.TheOncologist.com
Oxford University Press